Cellebrite: Entering an AI-Driven Growth Phase with Strengthening Competitive Moat and Upside Potential

William Blair analyst Jonathan Ho has maintained their bullish stance on CLBT stock, giving a Buy rating yesterday.

Jonathan Ho has given his Buy rating due to a combination of factors that indicate Cellebrite is entering a stronger growth phase supported by product innovation and AI integration. He views the company’s platform as increasingly strategic for law enforcement and enterprise customers, reinforced by high customer satisfaction and sizable investments in Cellebrite’s tools relative to competitors.

Ho also sees the firm’s established role as a trusted, compliant system of record as a meaningful moat, limiting displacement risk even as AI adoption accelerates. While he acknowledges emerging technical risks from advancements like Claude’s Mythos, he believes Cellebrite’s expanding software portfolio, AI‑enabled workflows, and growing adoption of Guardian and Pathfinder position the company to reap returns from prior investments and sustain attractive upside potential for the stock.

Ho covers the Technology sector, focusing on stocks such as Tyler Technologies, Via Transportation, Inc. Class A, and Fortinet. According to TipRanks, Ho has an average return of -8.5% and a 31.25% success rate on recommended stocks.

In another report released yesterday, TD Cowen also reiterated a Buy rating on the stock with a $23.00 price target.